Navigation Links
Discovery Could Lead To Novel Approaches In HIV Treatment

CANVAC, the Canadian Network for Vaccines and Immunotherapeutics, has announced the development of a new method to assess how well the thymus (an organ located at the base of the neck) works and the discovery of a functional abnormality of this organ in HIV-infected individuals. The team of investigators led by Dr. Rafick-Pierre Sékaly, professor at Université de Montréal, scientist at the CHUM Research Centre, and Scientific Director and Program Leader of CANVAC, publishes today its discoveries in Immunity, a prestigious scientific journal. This work was performed in collaboration with investigators from the Research Institute of the McGill University Health Centre as well as from France and Israel.

Using only blood samples, these researchers first developed a method to assess how well the thymus functions. The thymus is involved in the development of T-lymphocytes, an essential component of the immune system. T-lymphocytes also happen to be HIV's preferred targets for infection. The researchers then used this method to study blood samples from patients that had been recently infected with HIV and found that, already in the first months following the onset of infection, thymic function is decreased. Such a decrease results in a lowered T-lymphocyte production by the thymus. These findings pave the way to the development of novel immunotherapies of HIV-infected individuals. Such immunotherapies could be also applicable to patients requiring bone marrow transplantation to cure their cancer.
'"/>

Source:CANVAC press release


Page: 1

Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
3. UCSD Discovery Shows How Embryonic Stem Cells Perform Quality Control Inspections
4. Discovery Promises Simpler Therapy for Sickle Cell Disease
5. Discovery may lead to better Candidiasis drug
6. Protein Discovery Could Unlock The Secret To Better TB Treatment
7. Discovery clarifies role of peptide in biological clock
8. Eliminate Data Analysis Bottlenecks in Drug Discovery
9. Discovery of New Dopamine Action May Yield Alternative Psychiatric Drugs
10. Discovery could be key to bioterrorism defense
11. Discovery of an American salamander where it shouldnt be: Korea
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2019)... ... 09, 2019 , ... Akadeum Life Sciences today announced at ... microbubble technology. Unlike magnetic-based products, microbubbles use buoyancy to gently separate cells of ... participated in an early access program has been very encouraging and has led ...
(Date:5/8/2019)... QUEBEC CITY (PRWEB) , ... May 08, 2019 ... ... new small sensor, with a diameter of 200 microns and a lead-in fiber ... again establishing the new industry standard and positioning itself as the world leader ...
(Date:5/2/2019)... ... May 01, 2019 , ... Gateway Genomics , ... children, announces a new publication titled, “ Self-Collection of Maternal Blood for Fetal ... Health. Previous studies had only shown early gender determination using venous blood. When ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene ... Society's leadership team, including a new addition to the presidential line of succession, at ... to join the Society's leadership team for a three-year term (2019-2021). , All five ...
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:4/4/2019)... ... April 02, 2019 , ... ... announced it would be releasing it’s latest field-ready solution for performing PCR, RT-PCR, ... next-gen thermocycler Franklin™ pays homage to Rosland Franklin, an English chemist and X-ray ...
(Date:3/29/2019)... ... 28, 2019 , ... Specific Diagnostics announced today that, based ... second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test (AST) instrument. ... $1.7 million already awarded by CARB-X. The additional $1.7M will enable Specific’s preparation ...
Breaking Biology Technology: